INVESTMENTS TO ADDRESS HEALTH INEQUITIES IN PROSTATE CANCER CARE Movember funds three Australian programs targeting under-served populations
SEGMENT
Filmed in Melbourne | February 2025
INTERVIEWS
Sarah Weller
Global Director – Prostate Cancer, Movember
Kris Bennett,
Director – Prostate Cancer Health Equity, Movember
Movember is committed to advancing new research, cutting-edge treatments, and healthy behaviours, and advocating for inclusive, gender-responsive healthcare that caters to the unique needs of men, women, and gender-diverse individuals from diverse cultural backgrounds. In doing so, they hope to forge a future where barriers to healthy living are overcome, stigmas are removed, and where everyone has an equal opportunity to live a long, healthy life.
Income, education, geographical location, and discrimination based on ethnicity, race, gender and sexual orientation, are only a fraction of factors that can negatively affect a person’s quality of cancer care. This is defined as the “equity gap” and it’s costing people their lives.
Timed to coincide with World Cancer Day 4th February 2025, Movember announced prostate cancer investment of $5.5 million. Eighteen grants (16 proposals and 2 community development grants) are slated to directly tackle inequities in prostate cancer care. The funding will be over three years with the grants spread across five countries – six in Canada, five in the United Kingdom, three in Australia, three in the United States and one in Ireland – each having a specific focus population and care area.
AUSTRALIAN FUNDING FOR TARGETED PROSTATE CANCER CARE OUTREACH PROGRAMS
– The prostate cancer mortality rate in remote areas is almost 20% higher than in major cities. Access to treatment is the leading cause. This equity gap is what the Royal Flying Doctor Service of Australia’s grant will address, to improve access to and use of prostate cancer treatment services in rural and remote areas.
– Currently, prostate cancer data on the culturally and linguistically diverse communities of South Western Sydney is insufficient. That’s the first roadblock to improving this historically overlooked group’s prostate cancer care. The George Institute for Global Health aims to fill in the blanks with population level data to help close this equity gap.
– Australian Prostate Centre will create culturally appropriate prostate cancer services and practices for the LGBTQIA+ community, to counter the fear of discrimination and stigma that often stands in its way of getting prostate cancer screenings and diagnoses.
Australian Health Journal spoke with Movember about these targeted outreach programs in Australia and the hope they will help provide education and empower historically and intentionally excluded communities, using community stakeholders and voices to build trust. Collaborations with healthcare providers, academic institutions, and community-based organisations will share resources and expertise to develop tailored solutions.
-
Clinical entrepreneur addresses needle-phobia
Australian entrepreneur, Lauren Barber, turned her nursing background into the role of an inventor and launched a medical device into the Australian healthcare industry.
No journey is linear for an entrepreneur, but Lauren has travelled considerable distance from a nursing student to a successful entrepreneur illustration her determination and passion to help those with needle phobias. Lauren’s work with NeedleCalm is making a positive impact in the healthcare industry and improving the experiences of patients and clinicians alike.
-
Diary of a Paramedic in a primary health care clinic
Alecka Miles is a lecturer at Edith Cowan University and works as a paramedic in a multidisciplinary team at Dianella Family Medical Centre in Metropolitan Perth, Western Australia.
Community paramedic roles have a history in Australia, dating back to 2007 in New South Wales and followed by similar initiatives in South Australia and New Zealand. Alecka’s position emerged after she sought to evaluate how paramedics could integrate into general practice, ultimately leading to a job offer post-COVID lockdown in 2020. Her skills, particularly in cannulation, proved valuable as healthcare shifted towards primary care.
-
New treatment options under investigation for pelvic organ prolapse
Dr Shayanti Mukherjee, Research Group Head, Translational Tissue Engineering at the with her team at Hudson Institute of Medical Research is developing new ways to prevent and potential cure pelvic organ prolapse (POP). The technology aims to ultimately lead to safer and more effective treatment for women with pelvic organ prolapse (POP) using a woman’s own stem cells to boost the effectiveness of a degradable mesh.
